Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate

Meredith Sadinski1, Milica Medved2, Ibrahim Karademir3,4

  • 1Department of Radiology, University of Chicago, 5841 S. Maryland Avenue, MC 2026, Chicago, IL, 60637, USA. sadinski@uchicago.edu.

Abdominal Imaging
|March 26, 2015
PubMed
Abstract

Insights

Short-term diffusion-weighted MRI (DW-MRI) shows good reproducibility for prostate cancer assessment. Apparent diffusion coefficient (ADC) variation is approximately 10%, supporting its use in clinical settings.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Diffusion-weighted magnetic resonance (DW-MR) imaging is crucial for prostate cancer evaluation.
  • Understanding the short-term reproducibility of apparent diffusion coefficient (ADC) measurements is essential for reliable diagnosis and monitoring.

Purpose of the Study:

  • To determine the short-term reproducibility of apparent diffusion coefficient (ADC) values in the prostate using diffusion-weighted magnetic resonance (DW-MR) imaging.
  • To quantify variations in ADC measurements within different regions of the prostate and in cancerous regions of interest (ROIs).

Main Methods:

  • Fourteen patients with biopsy-proven prostate cancer underwent two consecutive DW-MR scans on a 3T system.
  • Apparent diffusion coefficient (ADC) values were calculated, and deformable registration aligned corresponding images.
  • Per-voxel and per-ROI variations in ADC were analyzed across prostate sextants and within cancerous ROIs.

Main Results:

  • Per-voxel absolute difference in prostate ADC ranged up to 1.60 × 10(-3) mm(2)/s (mean 10.5% relative difference).
  • ADC variation was highest in the posterior apex (mean 11.6%).
  • Cancer ROIs showed per-voxel ADC variation up to 67.4% (mean 11.2%) and per-ROI variation with a mean of 0.122 × 10(-3) mm(2)/s.

Conclusions:

  • Apparent diffusion coefficient (ADC) variation within the human prostate is relatively small, averaging around 10%.
  • These findings support the short-term reproducibility of DW-MR imaging for prostate cancer assessment.